Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) covers five more HPV types than predecessor Gardasil, both manufactured by Merck Sharp & Dohme Corp., subsidiary of Merck & Co. Click here for the full story.
Earn an educational grant from CPP to help offset the cost of investing in proper vaccine storage equipment. Educate yourself on the new CDC guidelines published in 2012 to make sure you aren’t putting your vaccine stock at risk. CPP provides educational resources around proper vaccine storage that include a list of recommended units from other CPP members.
Through the implementation of enhanced temperature monitoring procedures, many of our member practices have discovered failures in their refrigerators and freezers that have previously gone undetected. This discovery has led them to purchase new equipment that complies with the new guidelines, develop new procedures for greater oversight and create contingency plans in case of equipment or process failure. As you can imagine, this can be a very expensive venture for your practice but it could be even more expensive if you were to lose thousands of dollars’ worth of vaccines. CPP will continue to support our member offices in protecting their vaccine investments.
Infants were hit particularly hard as officials call for greater efforts to vaccinate pregnant women. Click here for the full article.
Many CPP members have utilized the “Vaccine Safety and your Child” booklet authored by Dr. Paul Offit and Charlotte Moser when discussing vaccines with patients and their families. A read-only version is available online or the booklets can be purchased for $1 each through the Children’s Hospital of Philadelphia (CHOP) Vaccine Education Center.
Please tell us what resources work well for you and your practice so that we can share with other CPP members!
The Children’s Hospital of Philadelphia (CHOP) and the AAP Pennsylvania Chapter sponsored a webinar discussing current issues in vaccines. Dr. Paul Offit discussed the following:
- Conflicting data and AAP recommendation regarding the use of Flumist in patients aged 2-8 years
- Expectations for the next generation 9-valent HPV that is awaiting FDA approval
- Anticipated utilization of the new meningococcal B vaccines
Click here to access the webinar.
We at CPP are thankful for our loyal members! It is because of you that we are able to provide such a great vaccine savings program and valuable educational resources to primary care providers across the country.
Despite the fact that many practices have received their flu shipments later in the season this year compared to prior years, CPP members have received 94% of all flu doses they reserved with Sanofi Pasteur to date. Depending on the presentation and quantity ordered by your practice, you may have seen more or less than this average.
CPP members who are also Sanofi Pasteur Fluzone Partners (flu reservations were confirmed by March 31, 2014), had the following shipping guarantees in place for all presentations except high dose for this flu season:
20% of reserve flu order by August 31, 2014
75% of reserve flu order by September 30, 2014
100% of reserve flu order by October 31, 2014
If these shipping commitments were not met for your practice, you may be eligible for credits to use towards future purchases for the 2015-2016 flu season. Please reach out to your Sanofi Pasteur representative during 2015-2016 pre-book period (January-March 2015) if you feel you are eligible for these credits.
Pediatric Care Online, the AAP’s online clinical resource, has received a facelift and the new site was launched in October. Check out www.pediatriccareonline.org to see the changes which includes combining the Red Book Online, Patient Education Online and Pediatric Care online into one tool!
Please remember CPP members receive free access to PCO as a member benefit. To sign-up your practice or for more information, contact the CPP office.
What professional resources do you use to stay current with recommendations, references, guides and industry best practices?
Click here to access the article.
In the last few weeks, we have seen price increase announcements on most of the routine vaccines you are providing to patients in your practice. While price increases are difficult for all parties to endure, here are some strategies you can employ to help minimize the negative impact to your practice’s bottom line:
- Join a buying group like CPP to access discounts on your vaccines.
- Make sure both your Sanofi Pasteur and Merck direct accounts are linked to the CPP contract to increase savings and maximize your CPP rebate potential.
- CPP members also enjoy an extended discount period during which Sanofi Pasteur and Merck vaccines can be purchased at pre-increase prices before the new prices take effect. Stock up on vaccines at the pre-increase price if you can!
- Notify your payers of the new prices as soon as possible. Most payers adjust their payment schedules quarterly. You can advocate for increased vaccine payment by referring insurance companies to the CDC Vaccine Price List for up to date private sector pricing.
Please also remember that the AAP put together a business case for providing vaccines in your practice. This tool should help guide you in making sure you are fairly compensated for the service you are providing your patients and the population in general.